Symetis has developed exceptionally easy to use, intuitive transcatheter delivery systems with a flexible shaft and ergonomic design that allow for a controlled, sheathless, 2-step implantation. The systems’ intelligent design results in a short learning curve for physicians, and safe procedures for patients.

The ACURATE TA transapical aortic bioprosthesis consists of three non-coronary native porcine leaflets attached to a self-expanding nitinol stent and a PET skirt sutured onto the inner and the outer surface of the stent. It is self-seating and self-sealing, allows for optimal positioning of the valve, and reduces paravalvular leak.

The ACURATE neo™ transfemoral aortic bioprosthesis is composed of a porcine pericardial tissue valve sutured within a self-expanding nitinol stent covered by a pericardial skirt on the outer and inner surface of the stent body. ACURATE neo is self-seating and self-sealing, allows for optimal positioning of the valve, and reduces paravalvular leak.

Our mission is to be a leader in establishing minimally-invasive transcatheter heart valve implantation devices to treat valvular heart disease. Our safe and intuitive aortic heart valve replacement systems alleviate the burden of disease of high-risk patients suffering from severe aortic stenosis. Our devices give physicians greater control during delicate surgical interventions, and result in superb patient outcomes.

State-of-the-art transcatheter aortic valve implantation (TAVI) systems
Commitment to put the best TAVI systems at the service of physicians and patients
Innovation in close collaboration with heart teams
Intuitive, step-wise delivery systems with outstanding ease-of-use and controlled valve release